Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Completed · Phase 2

Conditions studied: Neovascular Age-Related Macular Degeneration

In brief

The primary objective of the study is to compare the efficacy of intravitreal (IVT)-administered REGN910-3 compared to intravitreal aflibercept injection (IAI).

Key facts

Study ID

NCT02713204

Run by

Regeneron Pharmaceuticals

People needed

365

Starts

2016-03-31

Expected to finish

2017-10-03

Last updated by the study team

2019-05-07

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Regeneron Investigational Site 1 — Phoenix, Arizona, United States
• Regeneron Investigational Site 2 — Phoenix, Arizona, United States
• Regeneron Investigational Site 3 — Phoenix, Arizona, United States
• Regeneron Investigational Site 1 — Tucson, Arizona, United States
• Regeneron Investigational Site 2 — Tucson, Arizona, United States
• Regeneron Investigational Site — Arcadia, California, United States
• Regeneron Investigational Site — Bakersfield, California, United States
• Regeneron Investigational Site — Beverly Hills, California, United States
• Regeneron Investigational Site — Encino, California, United States
• Regeneron Investigational Site 1 — Los Angeles, California, United States
• Regeneron Investigational Site 2 — Los Angeles, California, United States
• Regeneron Investigational Site — Mountain View, California, United States
• Regeneron Investigational Site — Oceanside, California, United States
• Regeneron Investigational Site 1 — Palm Desert, California, United States
• Regeneron Investigational Site 2 — Palm Desert, California, United States
• Regeneron Investigational Site — Palo Alto, California, United States
• Regeneron Investigational Site — Poway, California, United States
• Regeneron Investigational Site — Redlands, California, United States
• Regeneron Investigational Site — Sacramento, California, United States
• Regeneron Investigational Site — Santa Maria, California, United States
• Regeneron Investigational Site — New London, Connecticut, United States
• Regeneron Investigational Site — Altamonte Springs, Florida, United States
• Regeneron Investigational Site — Fort Lauderdale, Florida, United States
• Regeneron Investigational Site — Lakeland, Florida, United States
• Regeneron Investigational Site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.